Logo image of GL9.I

GLANBIA PLC (GL9.I) Stock Fundamental Analysis

Europe - Euronext Dublin - DUB:GL9 - IE0000669501 - Common Stock

14.6 EUR
+0.23 (+1.6%)
Last: 12/29/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to GL9. GL9 was compared to 58 industry peers in the Food Products industry. While GL9 has a great health rating, its profitability is only average at the moment. GL9 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

GL9 had positive earnings in the past year.
In the past year GL9 had a positive cash flow from operations.
Each year in the past 5 years GL9 has been profitable.
Each year in the past 5 years GL9 had a positive operating cash flow.
GL9.I Yearly Net Income VS EBIT VS OCF VS FCFGL9.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

GL9's Return On Assets of 3.10% is in line compared to the rest of the industry. GL9 outperforms 53.45% of its industry peers.
GL9 has a Return On Equity of 5.89%. This is comparable to the rest of the industry: GL9 outperforms 50.00% of its industry peers.
GL9 has a better Return On Invested Capital (9.81%) than 91.38% of its industry peers.
GL9 had an Average Return On Invested Capital over the past 3 years of 9.21%. This is above the industry average of 6.30%.
The 3 year average ROIC (9.21%) for GL9 is below the current ROIC(9.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.1%
ROE 5.89%
ROIC 9.81%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
GL9.I Yearly ROA, ROE, ROICGL9.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 3.06%, GL9 perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
In the last couple of years the Profit Margin of GL9 has declined.
GL9's Operating Margin of 9.38% is fine compared to the rest of the industry. GL9 outperforms 68.97% of its industry peers.
In the last couple of years the Operating Margin of GL9 has grown nicely.
Looking at the Gross Margin, with a value of 27.51%, GL9 is doing worse than 68.97% of the companies in the same industry.
GL9's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.38%
PM (TTM) 3.06%
GM 27.51%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
GL9.I Yearly Profit, Operating, Gross MarginsGL9.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GL9 is creating some value.
GL9 has less shares outstanding than it did 1 year ago.
GL9 has less shares outstanding than it did 5 years ago.
The debt/assets ratio for GL9 is higher compared to a year ago.
GL9.I Yearly Shares OutstandingGL9.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
GL9.I Yearly Total Debt VS Total AssetsGL9.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

GL9 has an Altman-Z score of 3.53. This indicates that GL9 is financially healthy and has little risk of bankruptcy at the moment.
GL9 has a better Altman-Z score (3.53) than 84.48% of its industry peers.
GL9 has a debt to FCF ratio of 3.82. This is a good value and a sign of high solvency as GL9 would need 3.82 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.82, GL9 belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that GL9 is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.50, GL9 is doing good in the industry, outperforming 60.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.82
Altman-Z 3.53
ROIC/WACC1.47
WACC6.66%
GL9.I Yearly LT Debt VS Equity VS FCFGL9.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

GL9 has a Current Ratio of 1.67. This is a normal value and indicates that GL9 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GL9 (1.67) is better than 68.97% of its industry peers.
A Quick Ratio of 0.89 indicates that GL9 may have some problems paying its short term obligations.
GL9's Quick ratio of 0.89 is in line compared to the rest of the industry. GL9 outperforms 53.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 0.89
GL9.I Yearly Current Assets VS Current LiabilitesGL9.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

The earnings per share for GL9 have decreased strongly by -58.14% in the last year.
Measured over the past 5 years, GL9 shows a small growth in Earnings Per Share. The EPS has been growing by 7.31% on average per year.
Looking at the last year, GL9 shows a very negative growth in Revenue. The Revenue has decreased by -11.61% in the last year.
Measured over the past years, GL9 shows a decrease in Revenue. The Revenue has been decreasing by -0.19% on average per year.
EPS 1Y (TTM)-58.14%
EPS 3Y-0.29%
EPS 5Y7.31%
EPS Q2Q%-7.35%
Revenue 1Y (TTM)-11.61%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%6.12%

3.2 Future

Based on estimates for the next years, GL9 will show a small growth in Earnings Per Share. The EPS will grow by 4.43% on average per year.
The Revenue is expected to grow by 2.78% on average over the next years.
EPS Next Y-5.04%
EPS Next 2Y1.42%
EPS Next 3Y3.6%
EPS Next 5Y4.43%
Revenue Next Year1.75%
Revenue Next 2Y2.11%
Revenue Next 3Y2.53%
Revenue Next 5Y2.78%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GL9.I Yearly Revenue VS EstimatesGL9.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
GL9.I Yearly EPS VS EstimatesGL9.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

GL9 is valuated correctly with a Price/Earnings ratio of 12.70.
Compared to the rest of the industry, the Price/Earnings ratio of GL9 indicates a somewhat cheap valuation: GL9 is cheaper than 74.14% of the companies listed in the same industry.
GL9 is valuated cheaply when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.95 indicates a reasonable valuation of GL9.
GL9's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. GL9 is cheaper than 63.79% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GL9 to the average of the S&P500 Index (23.40), we can say GL9 is valued slightly cheaper.
Industry RankSector Rank
PE 12.7
Fwd PE 11.95
GL9.I Price Earnings VS Forward Price EarningsGL9.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GL9 is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, GL9 is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.47
EV/EBITDA 8.92
GL9.I Per share dataGL9.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of GL9 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.74
EPS Next 2Y1.42%
EPS Next 3Y3.6%

3

5. Dividend

5.1 Amount

GL9 has a Yearly Dividend Yield of 2.18%.
GL9's Dividend Yield is comparable with the industry average which is at 2.31.
Compared to an average S&P500 Dividend Yield of 2.00, GL9 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

On average, the dividend of GL9 grows each year by 33.32%, which is quite nice.
Dividend Growth(5Y)33.32%
Div Incr Years6
Div Non Decr Years6
GL9.I Yearly Dividends per shareGL9.I Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

GL9 pays out 92.88% of its income as dividend. This is not a sustainable payout ratio.
GL9's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP92.88%
EPS Next 2Y1.42%
EPS Next 3Y3.6%
GL9.I Yearly Income VS Free CF VS DividendGL9.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
GL9.I Dividend Payout.GL9.I Dividend Payout, showing the Payout Ratio.GL9.I Dividend Payout.PayoutRetained Earnings

GLANBIA PLC

DUB:GL9 (12/29/2025, 7:00:00 PM)

14.6

+0.23 (+1.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners27.1%
Inst Owner ChangeN/A
Ins Owners0.77%
Ins Owner ChangeN/A
Market Cap3.56B
Revenue(TTM)3.95B
Net Income(TTM)120.80M
Analysts80
Price Target17.91 (22.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend0.31
Dividend Growth(5Y)33.32%
DP92.88%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.17%
PT rev (3m)5.15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.36%
EPS NY rev (3m)0.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 12.7
Fwd PE 11.95
P/S 1.06
P/FCF 15.47
P/OCF 11.62
P/B 2.05
P/tB 9.54
EV/EBITDA 8.92
EPS(TTM)1.15
EY7.88%
EPS(NY)1.22
Fwd EY8.37%
FCF(TTM)0.94
FCFY6.46%
OCF(TTM)1.26
OCFY8.61%
SpS13.75
BVpS7.13
TBVpS1.53
PEG (NY)N/A
PEG (5Y)1.74
Graham Number13.59
Profitability
Industry RankSector Rank
ROA 3.1%
ROE 5.89%
ROCE 12.36%
ROIC 9.81%
ROICexc 10.74%
ROICexgc 24.2%
OM 9.38%
PM (TTM) 3.06%
GM 27.51%
FCFM 6.86%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
ROICexc(3y)10.65%
ROICexc(5y)8.91%
ROICexgc(3y)25.6%
ROICexgc(5y)20.78%
ROCE(3y)11.85%
ROCE(5y)10%
ROICexgc growth 3Y28.93%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y21.85%
ROICexc growth 5Y8.02%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.82
Debt/EBITDA 1.92
Cap/Depr 56.68%
Cap/Sales 2.28%
Interest Coverage 11.4
Cash Conversion 68.24%
Profit Quality 224.5%
Current Ratio 1.67
Quick Ratio 0.89
Altman-Z 3.53
F-Score6
WACC6.66%
ROIC/WACC1.47
Cap/Depr(3y)51.28%
Cap/Depr(5y)53.27%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.68%
Profit Quality(3y)136.16%
Profit Quality(5y)132.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-58.14%
EPS 3Y-0.29%
EPS 5Y7.31%
EPS Q2Q%-7.35%
EPS Next Y-5.04%
EPS Next 2Y1.42%
EPS Next 3Y3.6%
EPS Next 5Y4.43%
Revenue 1Y (TTM)-11.61%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%6.12%
Revenue Next Year1.75%
Revenue Next 2Y2.11%
Revenue Next 3Y2.53%
Revenue Next 5Y2.78%
EBIT growth 1Y-0.4%
EBIT growth 3Y19.97%
EBIT growth 5Y12.85%
EBIT Next Year25.42%
EBIT Next 3Y12.49%
EBIT Next 5Y10.6%
FCF growth 1Y-12.01%
FCF growth 3Y21.96%
FCF growth 5Y21.96%
OCF growth 1Y-6.33%
OCF growth 3Y16.3%
OCF growth 5Y16.3%

GLANBIA PLC / GL9.I FAQ

Can you provide the ChartMill fundamental rating for GLANBIA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to GL9.I.


Can you provide the valuation status for GLANBIA PLC?

ChartMill assigns a valuation rating of 5 / 10 to GLANBIA PLC (GL9.I). This can be considered as Fairly Valued.


What is the profitability of GL9 stock?

GLANBIA PLC (GL9.I) has a profitability rating of 6 / 10.


What is the financial health of GLANBIA PLC (GL9.I) stock?

The financial health rating of GLANBIA PLC (GL9.I) is 7 / 10.


What is the expected EPS growth for GLANBIA PLC (GL9.I) stock?

The Earnings per Share (EPS) of GLANBIA PLC (GL9.I) is expected to decline by -5.04% in the next year.